Advertisement
Correspondence| Volume 220, P140-141, January 2018

Oocyte vitrification for preserving fertility in patients with endometriosis: first observational cohort study… and many unresolved questions. Letter to the Editor

  • Jade Raad
    Affiliations
    Department of Reproductive Medicine and Fertility Preservation, Hôpital Jean Verdier, Avenue du 14 Juillet, 93140 Bondy, France
    Search for articles by this author
  • Charlotte Sonigo
    Affiliations
    Department of Reproductive Medicine and Fertility Preservation, Hôpital Jean Verdier, Avenue du 14 Juillet, 93140 Bondy, France

    Inserm U1185, Univ Paris-Sud, Université Paris Saclay, Le Kremlin Bicêtre, 94276, France
    Search for articles by this author
  • Chloé Tran
    Affiliations
    Department of Reproductive Medicine and Fertility Preservation, Hôpital Jean Verdier, Avenue du 14 Juillet, 93140 Bondy, France
    Search for articles by this author
  • Christophe Sifer
    Affiliations
    Department of Cytogenetic and Reproductive Biology, Hôpital Jean Verdier, Avenue du 14 Juillet, 93140 Bondy, France
    Search for articles by this author
  • Isabelle Cedrin Durnerin
    Affiliations
    Department of Reproductive Medicine and Fertility Preservation, Hôpital Jean Verdier, Avenue du 14 Juillet, 93140 Bondy, France
    Search for articles by this author
  • Michaël Grynberg
    Correspondence
    Corresponding author at: Department of Reproductive Medicine and Fertility Preservation, Hôpital Jean Verdier, avenue du 14 Juillet, 93140 Bondy, France.
    Affiliations
    Department of Reproductive Medicine and Fertility Preservation, Hôpital Jean Verdier, Avenue du 14 Juillet, 93140 Bondy, France

    University Paris XIII, 93000 Bobigny, France

    Inserm U1185, Univ Paris-Sud, Université Paris Saclay, Le Kremlin Bicêtre, 94276, France
    Search for articles by this author
Published:December 04, 2017DOI:https://doi.org/10.1016/j.ejogrb.2017.12.001
      Fertility preservation is now considered paramount for the well-being of women battling cancer. However, others indications have more recently emerged, ranging from benign diseases to elective oocyte cryopreservation [
      • Garcia-Velasco J.A.
      • Domingo J.
      • Cobo A.
      • Martínez M.
      • Carmona L.
      • Pellicer A.
      Five years’ experience using oocyte vitrification to preserve fertility for medical and nonmedical indications.
      ,
      • Grynberg M.
      • Benard J.
      Fertility preservation and endometriosis: when medical borders on social.
      ]. In particular, women with endometriosis may represent a suitable group since they are at risk for compromised ovarian reserve [
      • de Ziegler D.
      • Borghese B.
      • Chapron C.
      Endometriosis and infertility: pathophysiology and management.
      ]. Some authors attempted to develop the pros and cons of Fertility Preservation (FP) and speculate on which subgroups of women may benefit from the procedure [
      • Somigliana E.
      • Viganò P.
      • Filippi F.
      • Papaleo E.
      • Benaglia L.
      • Candiani M.
      • et al.
      Fertility preservation in women with endometriosis: for all, for some, for none?.
      ,
      • Carrillo L.
      • Seidman D.S.
      • Cittadini E.
      • Meirow D.
      The role of fertility preservation in patients with endometriosis.
      ]. However, data on FP in endometriosis patients remains extremely scarce. The present investigation aims to describe the first cohort of endometriosis patients having undergone oocyte vitrification and to draw some preliminary conclusions on FP in this subgroup of women.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      References

        • Garcia-Velasco J.A.
        • Domingo J.
        • Cobo A.
        • Martínez M.
        • Carmona L.
        • Pellicer A.
        Five years’ experience using oocyte vitrification to preserve fertility for medical and nonmedical indications.
        Fertil Steril. 2013; 99: 1994-1999
        • Grynberg M.
        • Benard J.
        Fertility preservation and endometriosis: when medical borders on social.
        Gynecol Obstet Fertil. 2015; 43: 759-760
        • de Ziegler D.
        • Borghese B.
        • Chapron C.
        Endometriosis and infertility: pathophysiology and management.
        Lancet Lond Engl. 2010; 376: 730-738
        • Somigliana E.
        • Viganò P.
        • Filippi F.
        • Papaleo E.
        • Benaglia L.
        • Candiani M.
        • et al.
        Fertility preservation in women with endometriosis: for all, for some, for none?.
        Hum Reprod Oxf Engl. 2015; 30: 1280-1286
        • Carrillo L.
        • Seidman D.S.
        • Cittadini E.
        • Meirow D.
        The role of fertility preservation in patients with endometriosis.
        J Assist Reprod Genet. 2016; 33: 317-323